Scientists Find Protein That May Cure Type 2 Diabetes

Scientists just uncovered a tiny protein hiding in our DNA that could transform how we treat Type 2 diabetes for millions of people.

Researchers at the University of Southern California found a microprotein called MENTSH tucked inside mitochondria, the powerhouses of our cells. This discovery came after analyzing genetic data from more than 15,000 adults and could open doors to precision treatments tailored to individual patients.

The team identified a common genetic variant that disables MENTSH production. This variant appears in 20% of Mexican and Mexican American individuals, populations that face higher rates of diabetes. The discovery finally offers a biological explanation for why these communities are disproportionately affected by the disease.

"For the first time, we've connected a mitochondrial microprotein to diabetes risk in a specific population," said co-author Jerome Rotter, a professor at the Lundquist Institute for Biomedical Innovation. This connection opens pathways to treatments designed for the people who need them most.

In laboratory studies with mice, MENTSH showed promising results. The protein improved how cells respond to insulin, a key factor in managing diabetes. Even more exciting, engineered versions of MENTSH powerfully blocked weight gain in mice eating high-fat diets.

What makes MENTSH special is how it works differently across body tissues. It activates beneficial signals in muscle while reducing them in fat, exactly the targeted effect doctors want in metabolic therapies. "This molecule appears to act differently in muscle versus fat, which is exactly the kind of targeted effect you'd want," said Research Associate Professor Kelvin Yen.

The genetic variant can be easily screened for with a simple test. This means doctors could one day identify people at higher diabetes risk and offer personalized preventive treatments before the disease develops.

Why This Inspires

This breakthrough represents more than just another diabetes study. It addresses a real health disparity affecting specific communities who have long faced higher disease rates without clear answers.

The research team brought together scientists from USC, the Salk Institute, UCLA, and UC Irvine, supported by the National Institutes of Health and multiple foundations. Their collaborative approach shows how modern science can tackle complex health challenges affecting vulnerable populations.

Senior author Pinchas Cohen calls MENTSH "a muscle-sparing weight loss peptide" that could help millions worldwide struggling with diabetes and obesity. The discovery not only offers hope for new treatments but also unravels why certain populations face greater disease burden.

The findings are still preclinical, meaning more safety and effectiveness studies are needed before human trials begin. But the potential is enormous for a future where diabetes treatment matches each person's unique genetic makeup.

Science just took a major step toward making precision medicine a reality for everyone.